Blood pressure and pulse wave velocity as metrics for evaluating pathologic ageing of the cardiovascular system

Blood Pressure

Volumn 23, Issue 1, 2014, Pages 17-30

  Nilsson, Peter M ^a   Khalili, Payam ^b   Franklin, Stanley S ^c  

^a LUND UNIVERSITY   (Sweden)

^b CENTRAL HOSPITAL   (Sweden)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Ageing; Blood pressure; Cardiovascular; Hemodynamics; Pulse wave velocity; Treatment

Indexed keywords

ELASTIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

AGE; AGING; ALZHEIMER DISEASE; ARTERIAL STIFFNESS; BLOOD PRESSURE; BLOOD PRESSURE MEASUREMENT; BODY MASS; BRACHIAL PULSE PRESSURE; BRAIN HEMORRHAGE; CARDIOMETABOLIC RISK; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CARDIOVASCULAR SYSTEM; CAROTID FEMORAL PULSE WAVE VELOCITY; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; EPIDEMIOLOGICAL DATA; ESSENTIAL HYPERTENSION; HALF LIFE TIME; HEART FAILURE; HEART INFARCTION; HEART OUTPUT; HEART STROKE VOLUME; HEART VENTRICLE EJECTION; HUMAN; HYPERTENSION; ISOLATED SYSTOLIC HYPERTENSION; LIFESTYLE MODIFICATION; MENTAL DETERIORATION; METABOLIC SYNDROME X; METRIC SYSTEM; MULTIINFARCT DEMENTIA; PRIORITY JOURNAL; PULSE PRESSURE; PULSE WAVE; REVIEW; SECONDARY ANALYSIS; SENESCENCE; SEX; SWEDEN; SYSTOLIC HYPERTENSION; TISSUE PERFUSION; UNITED STATES; VASCULAR AGING; WEIGHT REDUCTION;

AGE FACTORS; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; HUMANS; HYPERTENSION; PULSE WAVE ANALYSIS;

EID: 84896704994     PISSN: 08037051     EISSN: 16511999     Source Type: Journal    
DOI: 10.3109/08037051.2013.796142     Document Type: Review

References (78)

1. AD , Furberg CD. A ge as a modifi able risk factor for cardiovascular disease. Lancet. 2008 ; 371 : 1547-1551.
2. Nilsson PM. Early vascular aging (EVA): Consequences and prevention. Vasc Health Risk Manag. 2008 ; 4 : 547-552.
3. Nilsson PM, Lurbe E, Laurent S. The early life origins of vascular ageing and cardiovascular risk: The EVA syndrome (review). J. Hypertens. 2008 ; 26 : 1049-1057.
4. Nilsson PM, Boutouyrie P, Laurent S. Vascular aging: A tale of EVA and ADAM in cardiovascular risk assessment and prevention (Brief Review). Hypertension. 2009 ; 54 : 3-10.
5. Fagard RH , Van Den Froeke C, De Cort P. Prognostic signifi cance of blood pressure measured in the offi ce, at home and during ambulatory monitoring in older patients in general practice. J Hum Hypertens. 2005 ; 19 : 801-807.
6. Kannel WB, Vasan R, Levy D. I Sthe relation of systolic blood pressure to risk of cardiovascular disease continuous and graded, or are there critical values Hypertension. 2003 ; 42 : 453-456.
7. Prospective studies Collaboration. A ge-specifi Crelevance of usual blood pressure to vascular mortality: A meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002 ; 360 : 1903-1913.
8. McMahon S, Peto R, Cutler J , Collins R, Sorlie P, Neaton J , et al. Blood pressure, stroke, and coronary heart disease: Part Prolonged differences in blood pressure: Prospective observational studies corrected for the regression dilution bias. Lancet. 1990 ; 335 : 765-774.
9. Levy BJ, A mbrosio G, Pries A R, Struijker-Boudier HAJ. Microcirculation in hypertension. A new target for treatment Circulation. 2001 ; 104 : 735-740.
10. Levy BI, Schiffrin EL, Mourad JJ, A gostini D, Vicaut E, Safar ME , et al. Impaired tissue perfusion. A pathology common to hypertension, obesity, and diabetes mellitus. Circulation. 2008 ; 118 : 968-976.
11. Nichols W W , O Rourke MF. McDonald s blood fl ow in arteries: Theoretical, experimental and clinical principles. 5th ed. London: Hodder Arnold ; 2005.
12. Kannel W B. Risk stratifi cation in hypertension: New insights from the Framingham Study. Am J Hypertens. 2000 ; 13(1 Pt 2) : 3S-10S.
13. Scuteri A , Najjar SS , Muller DC , A ndres R, Hougaku H, Metter J , et al. Metabolic syndrome amplifi es the ageassociated increases in vascular thickness and stiffness. J Am Coll Cardiol. 2004 ; 43 : 1388-1395.
14. Schillaci G, Pirro M, Faudo G, Mannarino MR , Savarese G, Pucci G, et al. Metabolic syndrome is associated with aortic stiffness in untreated essential hypertension. Hypertension. 2005 ; 45 : 1078-1082.
15. Burt VL , Whelton P, Roccella EJ, Brown C, Cutler JA , Higgins M, et al. Prevalence of hypertension in the US adult population: Results from the Third National Health and Nutrition Examination Survey, 1988-1991. Hypertension. 1995 ; 25 : 305-313.
16. Franklin SS , Gustin W, Wong ND , Larson MG , Weber MA , Kannel WB , et al. Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study. Circulation. 1997 ; 96 : 308-315.
17. Pletcher MJ , Biffi ns-Domingo K, Lewis CE, Wei GS, Sidney S, Carr JJ , et al. Prehypertension during young adulthood and coronary calcium later in life. Ann Intern Med. 2008 ; 149 : 91-99.
18. Laurent S, Cockcroft J , Van Bortel L, Boutouyrie P, Giannattasio C, Hayoz D, et al. Expert consensus document on arterial stiffness: Methodological issues and clinical applications. Eur Heart J. 2006 ; 27 : 2588-2605.
19. McEniery CM , Y asmin , Hall IR , Q asem A , Wilkinson IB, Cockcroft JR ; ACCT Investigators. Normal vascular aging: Differential effects on wave refl ection and aortic pulse wave velocity: The Anglo-Cardiff Collaborative Trial (ACCT). J Am Coll Cardiol. 2005 ; 46 : 1753-1760.
20. Blacher J. Guerin AP , Pannier, Marchais SJ , Safar ME , London GM. Impact of aortic stiffness on survival in end-stage renal disease. Circulation. 1999 ; 99 : 2434-2439.
21. Laurent S, Boutouyrie P, Asmar R, Gautier I , Laloux B, Guize L, et al. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension. 2001 ; 37 : 1236-1241.
22. Benetos A , A samopouolos C, Bureau J-M, Temmar M, Labat C, Bean K, et al. Determinants of accelerated progression of arterial stiffness in normotensive subjects and in treated hypertensive subjects over a 6-year period. Circulation. 2002 ; 105 : 1202-1207.
23. Vlachopoulos C, A znaouridis K, Stefanadis C. Prediction of cardiovascular events and all-cause mortality with arterial stiffness: A systematic review and meta-analysis. J Am Coll Cardiol. 2010 ; 55 : 1318-1327.
24. Van Bortel LM, Laurent S, Boutouyrie P, Chowienczyk P, Cruickshank JK , De Backer T, et al.; Artery Society; European Society of Hypertension Working Group on Vascular Structure and Function ; European Network for Noninvasive Investigation of Large Arteries. Expert consensus document on the measurement of aortic stiffness in daily practice using carotid-femoral pulse wave velocity. J Hypertens. 2012 ; 30 : 445-448.
25. Reference Values for Arterial Stiffness Collaboration. Determinants of pulse wave velocity in healthy people and in the presence of cardiovascular risk factors: " Establishing normal and reference values ". Eur Heart J. 2010 ; 31 : 2338-2350.
26. Franklin SS , Khan SA , Wong ND , Larson MG , Levy D. I Spulse pressure useful in predicting risk for coronary heart disease The Framingham Heart Study. Circulation. 1999 ; 100 : 354-360.
27. Darne B, Girerd X , Safar M, Cambien F, Guize L. Pulsatile versus steady component of blood pressure: A cross-sectional analysis and a prospective analysis on cardiovascular mortality. Hypertension. 1989 ; 13 : 392-400.
28. Fang J. Madhavan S, Cohen H, Alderman MH. Measures of blood pressure and myocardial infarction in treated hypertensive patients. J Hypertens. 1995 ; 13 : 413-419.
29. Benetos A , Safar M, Rudnichi A , Smulyan H, Richard JL, Ducimetiere P, et al. Pulse pressure. A predictor of long-term cardiovascular mortality in a French male population. Hypertension. 1997 ; 30 : 1410-1415.
30. Lee MT , Rosner BA , Weiss CT. Relationship of blood pressure to cardiovascular death: The effect of pulse pressure in the elderly. Ann Epidemiol. 1999 ; 9 : 101-107.
31. Domanski MJ , Davis BR, Pfeffer MA , Kastantin M, Mitchell GF. Isolated systolic hypertension. Prognostic information provided by pulse pressure. Hypertension. 1999 ; 34 : 375-380.
32. Glynn RG , Chae CU , Guralnik JM , Taylor JO, Hennekens CH. Pulse pressure and mortality in older people. Arch Intern Med. 2000 ; 160 : 2765-2772.
33. Blacher J , Staessen J A , Girerd X, Gasowski J , Thijs L, Liu L, et al. Pulse pressure not mean pressure determines cardiovascular risk in older hypertensive patients. Arch Intern Med. 2000 ; 160 : 1085-1089.
34. Benetos A , Z ureik M, Morcet J , Thomas F, Bean K, Safar M, et al. A decrease in diastolic blood pressure combined with an increase in systolic blood pressure is associated with a higher cardiovascular mortality in men. J Am Coll Cardiol. 2000 ; 35 : 673-680.
35. Khattar RS , Swales JD , Dore C, Senior R, Lahiri A. Effect of aging on the prognostic signifi cance of ambulatory systolic, diastolic, and pulse pressure in essential hypertension. Circulation. 2001 ; 104 : 783-789.
36. Staessen JA , Gasowski, Wang JG , Lutgarde T, Hond ED , Boissel JP , et al. Risks of untreated and treated isolated systolic hypertension in the elderly meta-analysis of outcome trials. Lancet. 2000 ; 104 : 865-872.
37. Verdecchia P, Schillaci G, Borgione C, Ciucce A , Pede S, Porcellati C. Ambulatory pulse pressure: A potent predictor of total cardiovascular risk in hypertension. Hypertension. 1998 ; 32 : 983-988.
38. Franklin SS , Lopez VA , Wong ND , Mitchell GF, Larson MG , Vasan RS , et al. Single versus combined blood pressure components and risk for cardiovascular disease. The Framingham Heart Study. Circulation. 2009 ; 119 : 243-250.
39. Chobanian A V, Bakris GL , Black HR , Cushman WC, Green La , Izzo JL Jr, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7) report. JAMA. 2003 ; 289 : 2560-2572.
40. The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). 2007 Guidelines for the management of arterial hypertension. Eur Heart J. 2007 ; 28 : 1462-1536.
41. Pauca A L, O Rourke MF , Kon ND. Prospective evaluation of a method for estimating ascending aortic pressure from the radial artery pressure waveform. Hypertension. 2001 ; 38 : 932-937.
42. Kelly R, Fitchett D. Noninvasive determination of aortic input impedance and external left ventricular power output: A validation repeatability study of a new technique. J Am Coll Cardiol. 1992 ; 20 : 952-963.
43. Safar ME , Blacher J , Pannier B, Guerin AP , Marchais SJ , Guyonvarch PM , et al. Central pulse pressure and mortality in end-stage renal disease. Hypertension. 2002 ; 39 : 735-738.
44. Williams , Lacy PS, Thom SM , Cruickshank K, Stanton A , Collier D, et al. CAF É Investigators, CAF É Steering Committee and Writing Committee. Differential impact of blood pressure lowering drugs on central aortic pressure and clinical outcomes: Principal results of the Conduit Artery Function Evaluation (CAF É ) Study. Circulation. 2006 ; 113 : 1212-1225.
45. Roman MJ , Devereux RB , Kizer JR , Lee ET , Galloway JM , Ali T, et al. Central pressure more strongly relates to vascular disease and outcome than does brachial pressure: The Strong Heart Study. Hypertension. 2007 ; 50 : 197-203.
46. McEniery CM, Y asmin, McDonnell B, Munnery M, Wallace , Rowe CV , Cockcroft JR , Wilkinson IB. Central pressure: Variability and impact of cardiovascular risk Factors. The Anglo-Cardiff Collborative Trial II. Hypertension. 2008 ; 51 : 1476-1482.
47. Mitchell GF , Hwang SJ , Vasan RS , Larson MG , Pencina MJ , Hamburg NM , et al. Arterial stiffness and cardiovascular events: The Framingham Heart Study. Circulation. 2010 ; 121 : 505-511.
48. Fields LE , Burt VL , Cutler JA , Hughes J , Roccella EJ , Sorlie P. The burden of adult hypertension in the United States 1999 to 2000: A rising tide. Hypertension. 2004 ; 44 : 398-404.
49. Franklin SS , J acobs MJ , Wong ND , LItalien GJ , Lapuerta P. Predominance of isolated systolic hypertension among middle-aged and elderly US hypertensives. Hypertension. 2001 ; 37 : 869-874.
50. Vasan RS , Beiser A , Seshadri S, Larson MG , Kannel WB, DAgostino RB , et al. Residual lifetime risk for developing hypertension in middle-aged women and men. JAMA. 2002 ; 287 : 1003-1010.
51. Franklin SS , Pio J R, Wong ND , Larson MG , Leip EP, Vasan RS , et al. Predictors of new-onset diastolic and systolic hypertension. The Framingham Heart Study. Circulation. 2005 ; 111 : 1121-1127.
52. Najjar S, Scuteri A , Shetty V, Wright BA , Muller DC , Fleg JL , et al. Pulse wave velocity is an independent predictor of the longitudinal increase in systolic blood pressure and of incident hypertension in the Baltimore Longitudinal Study of Aging. J Am Coll Cardiol. 2008 ; 51 : 1377-1383.
53. Kaess BM, Rong J , Larson MG , Hamburg NM, Vita JA , Levy D, et al. Aortic stiffness, blood pressure progression, and incident hypertension. JAMA. 2012 ; 308 : 875-881.
54. Khalili P, Sundstr ö MJ , Franklin SS , J endle J , Lundin F, Jungner I , et al. Combined effects of brachial pulse pressure and sialic acid for risk of cardiovascular events during 40 years of follow-up in 37,843 individuals. J Hypertens. 2012 ; 30 : 1718-1724.
55. Khalili P, Nilsson PM , Nilsson JA , Berglund G. Smoking as a modifi er of the systolic blood pressure-induced risk of cardiovascular events and mortality: A population-based prospective study of middle-aged men. J Hypertens. 2002 ; 20 : 1759-1764.
56. Mokhtari A , Bellinetto-Ford L, Melander O , Nilsson PM. Determinants of increasing pulse pressure during 23 years follow-up as a marker of arterial stiffness and vascular ageing. Blood Press. 2008 ; 17 : 291-297.
57. Cushman W, Dubbert P. Nonpharmacologic approaches to therapy of hypertension. Endocrine Pract. 1997 ; 3 : 106-111
58. SHEP cooperative Research Group: Prevention of stroke by antihypertensive drug in older persons with isolated systolic hypertension. JAMA. 1991 ; 265 : 3255-3264.
59. Staessen JA , Fagard R, Thijs L, Celis H, A rabidze GG , Birkenh ä ger WH , et al. Randomized double-blind comparison of placebo and the active treatment for older patients with isolated systolic hypertension. Lancet. 1997 ; 350 : 757-764.
60. Wang J-G , Staessen JA , Gong L, Liu L. Chinese trial on isolated systolic hypertension in the elderly. Arch Intern Med. 2000 ; 160 : 211-220.
61. Staessen JA , Wang JG , Thijs L, Fagard R. O verview of the outcome trials in older patients with isolated systolic hypertension. J Human Hypertens. 1999 ; 13 : 859-863.
62. Gueyffi er F, Bulpitt C, Boissel J-P, Schron E, Ekbom T, Fagard R, et al. Antihypertensive drugs in very old people: A subgroup meta-analysis of randomized controlled trials. Lancet. 1999 ; 353 : 793-796.
63. Beckett NS , Peters R, Fletcher A E, Staessen JA, Liu L, Dumitrascu D, et al. Treatment of hypertension in patients 80 years of age or older. NEngl J Med. 2008 ; 358 : 1887-1898.
64. Waldstein SR , Rice SC , Thayer JF, Najjar SS , Scuteri A , Z onderman AB. Pulse pressure and pulse wave velocity are related to cognitive decline in the Baltimore Longitudinal Study of Aging. Hypertension. 2008 ; 51 : 991-994.
65. Mitchell GF, Van Buchem MA , Sigurdsson S, Gotal JD , Jonsdottir MK , Kjartansson Ó , et al. Arterial stiffness, pressure and fl ow pulsatility and brain structure and function: The Age, Gene/Environment Susceptibility-Reykjavik study. Brain. 2011 Nov ; 134(Pt 11) : 3398-3407.
66. Staessen JA , Richart T, Birkenhager WH. Less atherosclerosis and lower blood pressure for a meaningful life perspective with more brain. Hypertension. 2007 ; 49 : 389-400.
67. Gorelick PB , Scuteri A , Black SE , Decarli C, Greenberg SM , Iadecola C, et al.; American Heart Association Stroke Council, Council on Epidemiology and Prevention, Council on Cardiovascular Nursing, Council on Cardiovascular Radiology and Intervention, and Council on Cardiovascular Surgery and Anesthesia. Vascular contributions to cognitive impairment and dementia: A statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2011 ; 42 : 2672-2713.
68. Gaede P, Lund-Andersen H, Parving HH, Pedersen O. Effect of a multifactorial intervention on mortality in type 2 diabetes. NEngl J Med. 2008 ; 358 : 580-591.
69. O Rourke MF , Safar ME , Dzau V. The cardiovascular continuum extended: Aging effects on the aorta and microvasculature. Vasc Med. 2010 ; 15 : 461-468.
70. Safar ME , Nilsson PM , Blacher J, Mimran A. Pulse pressure, arterial stiffness, and end-organ damage. Curr Hypertens Rep. 2012 ; 14 : 339-344.
71. Ong KT , Delerme S, Pannier B, Safar ME , Benetos A , Laurent S, et al.; investigators. Aortic stiffness is reduced beyond blood pressure lowering by short-term and long-term antihypertensive treatment: A meta-analysis of individual data in 294 patients. J Hypertens. 2011 ; 29 : 1034-1042.
72. Boutouyrie P, Lacolley P, Briet M, Regnault V, Stanton A , Laurent S, et al. Pharmacological modulation of arterial stiffness. Drugs. 2011 ; 71 : 1689-1701.
73. S, Briet M, Boutouyrie P. A rterial stiffness as surrogate end point: Needed clinical trials. Hypertension. 2012 ; 60 : 518-522.
74. Nilsson PM. Genetic and environmental determinants of early vascular ageing (EVA). Curr Vasc Pharmacol. 2012 ; 10 : 700-701.
75. Nilsson PM. I mpact of vascular aging on cardiovascular disease: The role of telomere biology. J Hypertens. 2012 ; 30 Suppl : S9-S12.
76. S, Briet M, Boutouyrie P. A rterial stiffness as surrogate end point: Needed clinical trials. Hypertension. 2012 ; 60 : 518-522.
77. Nilsson PM. Genetic and environmental determinants of early vascular ageing (EVA). Curr Vasc Pharmacol. 2012 ; 10 : 700-701.
78. Nilsson PM. I mpact of vascular aging on cardiovascular disease: The role of telomere biology. J Hypertens. 2012 ; 30 Suppl : S9-S12.